Risk factors for mortality in ICU patients in 10 middle eastern countries: The role of healthcare-associated infections

ElsevierVolume 72, December 2022, 154149Journal of Critical CareHighlights•

The mortality rate in ICUs in the Middle East is high.

We have found non-modifiable and modifiable risk factors for death.

The modifiable risk factors of death that we have found are the health care associated infections.

To reduce mortality in ICUs, the best option is to prevent healthcare-associated infections.

AbstractPurpose

The International Nosocomial Infection Control Consortium (INICC) found a high mortality rate in ICUs of the Middle East (ME). Our goal was to identify mortality risk factor (RF) in ICUs of the ME.

Materials

From 08/01/2003 to 02/12/2022, we conducted a prospective cohort study in 236 ICUs of 77 hospitals in 44 cities in 10 countries of ME. We analyzed 16 independent variables using multiple logistic regression.

Results

66,440 patients, hospitalized during 652,167 patient-days, and 13,974 died.

We identified following mortality RF: Age (adjusted odds ratio (aOR):1.02;p < 0.0001) rising risk 2% yearly; length of stay (LOS) (aOR:1.02;p < 0.0001) rising the risk 2% per day; central line (CL)-days (aOR:1.01;p < 0.0001) rising risk 1% per day; mechanicalventilator (MV) utilization-ratio (aOR:14.51;p < 0.0001); CL-associated bloodstream infection (CLABSI) acquisition (aOR):1.49;p < 0.0001); ventilator-associated pneumonia (VAP) acquisition (aOR:1.50;p < 0.0001); female gender (OR:1.14;p < 0.0001); hospitalization at a public-hospital (OR:1.31;p < 0.0001); and medical-hospitalization (aOR:1.64;p < 0.0001). High-income countries showed lowest risk (aOR:0.59;p < 0.0001).

Conclusion

Some identified RF are unlikely to change, such as country income-level, facility ownership, hospitalization type, gender, and age. Some can be modified; LOS, CL-use, MV-use, CLABSI, VAP. So, to lower the mortality risk in ICUs, we recommend focusing on strategies to shorten the LOS, reduce CL and MV-utilization, and use evidence-based recommendations to prevent CLABSI and VAP.

Keywords

Intensive care unit

Critical care

Mortality

Risk factor

Nosocomial infection

Health-care associated infections

Middle East

View full text

© 2022 Elsevier Inc. All rights reserved.

留言 (0)

沒有登入
gif